Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
Cancers|February 13, 2026
Leveraging Landmark Analysis for Tailored Surveillance in Stage I Non-Small-Cell Lung CancerGiovanni Leuzzi, Federica Sabia, Matteo Calderoni, et al.
Tumori|May 2, 2018
The evolving landscape of criteria for evaluating tumor response in the era of cancer immunotherapy: From Karnofsky to iRECISTAlessandro Inno, Giuseppe Lo Russo, Matteo Salgarello, et al.
Translational Lung Cancer Research|February 3, 2017
Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the futureClaudia Proto, Martina Imbimbo, Rosaria Gallucci, et al.
Critical Reviews in Oncology/Hematology|September 18, 2017
Cognitive impairment and chemotherapy: a brief overviewMilena Vitali, Carla Ida Ripamonti, Fausto Roila, et al.
Therapeutic Advances in Medical Oncology|December 19, 2024
Sex differences in patients with Non-Small Cell Lung Cancer harboring driver fusions treated with tyrosine kinase inhibitors: a systematic reviewRita Leporati, Édouard Auclin, Daniel Morchón, et al.
Future Oncology (London, England)|July 25, 2019
Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapyGiulia Galli, Claudia Proto, Diego Signorelli, et al.
European Journal of Cancer (Oxford, England : 1990)|August 15, 2022
Continuous sunitinib schedule in advanced platinum refractory thymic epithelial neoplasms: A retrospective analysis from the ThYmic MalignanciEs (TYME) Italian collaborative groupGabriele Antonarelli, Chiara Corti, Paolo Andrea Zucali, et al.
Lung Cancer (Amsterdam, Netherlands)|March 3, 2020
Stereotatic radiotherapy in metastatic non-small cell lung cancer: Combining immunotherapy and radiotherapy with a focus on liver metastasesGiulia Corrao, Giulia Marvaso, Roberto Ferrara, et al.
International Journal of Molecular Sciences|March 14, 2026
HER2 Alterations in Non-Small Cell Lung Cancer: Emerging Perspectives on the Therapeutic LandscapePaola Muscolino, Elena Fassi, Diego Signorelli, et al.
Tumori|June 30, 2026
Beyond the calendar: A narrative review on chronobiological drivers of prognosis in resectable NSCLCGiovanni Leuzzi, Pamela Minicozzi, Paolo Verderio, et al.
Pageof 14